Introduction
Respiratory syncytial virus (RSV) is often associated with infants and young children. However, the virus can also cause serious illness in older adults and individuals with certain chronic health conditions. RSV infections may lead to lower respiratory tract disease, hospitalization, and complications involving the lungs and breathing, particularly in vulnerable populations.
Arexvy is a vaccine developed to help reduce the risk of RSV-related lower respiratory tract disease in eligible adults. The vaccine is approved for adults 60 years of age and older, as well as certain adults ages 50 through 59 who are considered at increased risk for severe RSV disease.
The vaccine uses recombinant protein technology combined with an adjuvant system designed to strengthen the body’s immune response. After vaccination, the immune system develops antibodies and protective defenses that may help reduce the severity and risk of RSV illness.
For many adults, vaccination may play an important role in seasonal respiratory illness prevention alongside other vaccines such as influenza and COVID-19 vaccines. Healthcare providers often evaluate individual risk factors, including age, chronic lung disease, heart disease, and immune system health, when recommending RSV vaccination.
Although many insurance plans and Medicare programs may provide coverage for Arexvy, out-of-pocket costs can still vary depending on pharmacy pricing, administration fees, and insurance benefits. Some individuals may search for affordability support or medication access resources to help manage vaccine-related expenses.
Prescription Hope works with individuals who are seeking ways to make medications and healthcare treatments more affordable. Through patient assistance support and medication access advocacy, eligible patients may be able to explore affordability options related to medications and vaccines like Arexvy.
Understanding how Arexvy works, who may benefit from vaccination, possible side effects, and important safety information can help patients make informed decisions with their healthcare provider about RSV prevention.
What Is the Arexvy Patient Assistance Program?
Some brand-name medications, unfortunately, cost more than what the average American can afford out of pocket. This means many people are forced to decide between their medication and paying their bills.
Pharmaceutical manufacturers understand this and have developed a solution.
Many times, manufacturers not only bring their brand-name medications to market, but also develop Patient Assistance Programs. These offer qualified patients access to the brand-name medication at an affordable rate.
Unfortunately, patient assistance programs have been known to be complex to apply for. Many patients report feeling frustrated and overwhelmed during the application process, and confused by all of the requirements and steps to approval.
Thankfully, Prescription Hope has an answer.
How Expert Advocates Help Make Arexvy More Affordable
Professional Application Management
Prescription Hope is a comprehensive medication access service. This means we manage the entire application process for qualified patients.
We complete all necessary forms, collect required documents and healthcare provider signatures, and communicate with the manufacturer throughout the process.
We advocate on your behalf so that you can focus on what is most important to you – your loved ones and quality of life.
Predictable Monthly Pricing
Prescription Hope’s service fee is a predictable $70.00 per month, per medication. No hassles, surprises, or extra fees. Plus, there are no added medication costs. Your service fee covers all of our services plus the medication shipped directly to your door or doctor’s office.
Plus, if you do not qualify for your intended program, we’ll work to help you find other ways to save. Whether it’s substitute medications and their programs, coupons, discount cards, or other options, we’ll work to help you save.
And if we can’t help you save? Then you pay nothing.
Ongoing Advocacy and Refill Support
After your initial delivery of medication, we continue to work on your behalf. Our team of advocates monitors your program status, handles refill scheduling, updates documents as needed, and even takes care of yearly renewals.
Arexvy Patient Assistance Eligibility
Curious about your Arexvy eligibility? Wanting RSV vaccine assistance, but not sure whether you’re eligible?
The Arexvy Patient Assistance Program maintains its own qualification requirements. Just like any patient assistance program, the standard criteria typically fall into several categories. Some of those categories include:
Income level: Each program maintains its own income threshold criteria.
Insurance coverage: Coverage criteria may differ between programs.
Prescription: All programs require a valid prescription for the brand-name medication a patient is applying for.
U.S. residency: All patient assistance programs require an applicant to be a U.S. resident.
Simple Enrollment With Expert Support
Starting Your Journey
Ready to enroll in Arexvy assistance and get the RSV vaccine support you need?
It only takes 6 simple steps to enroll with Prescription Hope to access the Arexvy Patient Assistance Program:
- Submit Information: Complete our online enrollment form
- Advocate Contact: After we receive a completed enrollment form, a patient advocate will reach out within 1-2 business days.
- Document Collection: Once you’ve been prequalified, an advocate will collect all necessary documentation.
- Provider Coordination: Each application requires healthcare provider signatures. Our team handles gathering all the needed signatures.
- Program Submission: Once the application is ready, we submit it on your behalf.
- Medication Delivery: Following approval, manufacturers typically ship medications within 2 weeks. Medication ships directly from the manufacturer to your doorstep or doctor’s office.
Prescription Hope does not handle, store, or ship medications at any time.
Medication Delivery and Ongoing Support
After the initial delivery of your medication, Prescription Hope continues to help. We manage refill scheduling, document updates, yearly renewals, and more.
Understanding Arexvy
How Arexvy Works
Arexvy works by helping the immune system recognize and respond to respiratory syncytial virus (RSV). The vaccine contains a laboratory-made RSV protein combined with an adjuvant, which is designed to strengthen the body’s immune response after vaccination.
Once administered, the immune system produces antibodies and other protective immune defenses that may help reduce the risk of serious RSV-related lower respiratory tract disease. The adjuvant system included in Arexvy is intended to help generate a stronger and longer-lasting immune response, particularly in older adults whose immune systems may respond less effectively to vaccines over time.
Arexvy is administered as a single-dose intramuscular injection, typically in a pharmacy, clinic, physician’s office, or healthcare setting. Healthcare providers often recommend receiving the vaccine before RSV seasonal circulation begins.
What Conditions Does Arexvy Treat?
Arexvy is FDA-approved for the prevention of lower respiratory tract disease caused by RSV in:
- Adults 60 years of age and older
- Adults aged 50 through 59 who are at increased risk for RSV disease
RSV is a common respiratory virus that can cause serious complications in older adults and individuals with chronic medical conditions. In some cases, RSV infection may lead to bronchitis, pneumonia, hospitalization, or worsening of underlying heart and lung disease.
Individuals considered at higher risk for severe RSV illness may include those with:
- Chronic lung disease
- Chronic heart disease
- Weakened immune systems
- Advanced age
- Certain underlying medical conditions
Vaccination decisions are individualized based on a patient’s health history, risk factors, and provider recommendations.
Benefits of Treatment
For eligible adults, Arexvy may provide important protection against serious RSV-related illness and complications.
Potential benefits of Arexvy vaccination may include:
- Reduced risk of RSV-related lower respiratory tract disease
- Strong immune response supported by the vaccine adjuvant system
- Lower risk of severe respiratory complications associated with RSV
- Protection for older adults and certain high-risk individuals
- Support for seasonal respiratory illness prevention strategies
Clinical studies demonstrated significant protection against RSV-related lower respiratory tract disease in eligible adults receiving Arexvy.
Because RSV can be especially serious in older adults and individuals with chronic heart or lung disease, vaccination may help support overall respiratory health during seasonal virus circulation periods.
Important Safety Information and Side Effects
Like all vaccines, Arexvy may cause side effects and carries important safety considerations. Patients should discuss the risks and benefits of vaccination with their healthcare provider before receiving the vaccine.
Common side effects associated with Arexvy may include:
- Injection site pain
- Fatigue
- Muscle pain
- Headache
- Joint pain
- Mild fever
- Redness or swelling at the injection site
Most side effects are temporary and resolve within a few days after vaccination.
Severe allergic reactions can occur after vaccination, although these reactions are uncommon. Patients with a history of severe allergic reactions to vaccine components should not receive Arexvy.
Patients should seek immediate medical care if they experience symptoms of a severe allergic reaction, such as:
- Difficulty breathing
- Facial or throat swelling
- Severe rash or hives
- Dizziness or fainting
Syncope, or fainting, may occur after administration of injectable vaccines, including Arexvy. Healthcare providers may monitor patients briefly after vaccination to reduce the risk of injury related to fainting episodes.
Post-marketing safety monitoring has identified an increased risk of Guillain-Barré syndrome following vaccination with Arexvy. Patients should discuss their neurological history, current medical conditions, and vaccine history with their healthcare provider before vaccination.
Arexvy is not approved for use during pregnancy. Patients should discuss pregnancy-related considerations and current health conditions with their healthcare provider prior to vaccination.
Healthcare providers should also be informed about current illnesses, immune system conditions, and all medications before administration of the vaccine.
Access to Multiple Medications
If you’re looking for specialty medication assistance and know you have multiple medications that you struggle to afford, then Prescription Hope may be able to help.
We work with hundreds of brand-name medications and their patient assistance programs. This means that whether you qualify for one or many brand-name medication programs, we can help.
For every medication, our service rate is $70.00 per month, per medication.
Why Choose Prescription Hope for Arexvy Assistance
Experienced Advocacy Support
We’ve helped countless patients across America for over 20 years. This means our patients have saved hundreds of millions of dollars in medication costs.
Ongoing Medication Management
We don’t stop after you’re approved. We continue to manage refill scheduling, document updates, and yearly renewals.
Transparent Monthly Pricing
Our service fee is $70.00 per month, per med. That’s it. No hassles, hidden fees, or surprises.
Nationwide Medication Access Support
Our network has included hundreds of manufacturers and tens of thousands of healthcare providers.
If you need affordable Arexvy assistance and are looking to apply for the Arexvy Patient Assistance Program through Prescription Hope, then simply fill out our online enrollment form today and see if we can help you save!
